Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Medicare Making Changes to Improve Behavioral Health Care Access

Client Alert

The Centers for Medicare & Medicaid Services (CMS) recently announced changes to Medicare beneficiaries’ ability to access behavioral health care.

Currently, Medicare covers psychiatric hospitalization for people with acute psychiatric needs, partial hospitalization program services, and outpatient mental health treatment and therapy services. As mental health diagnoses for Medicare-eligible Americans increase, there has been a notable gap in coverage for certain services and certain providers.

In response, Medicare has implemented the following changes:

  1. Permitting Marriage and Family Therapists and Mental Health Counselors (including alcohol and drug counselors who meet the Mental Health Counselor requirements) to independently enroll in Medicare. To date, these providers could not independently enroll as Medicare providers.
  2. Paying for Community Health Integration and Principal Illness Navigation services. Notably, CMS is permitting these services to be provided by community health workers and peer support specialists. These services are especially important for beneficiaries whose social needs (i.e., food, housing, and transportation) interfere with their receipt of health care.
  3. Changing the required level of supervision for behavioral health services performed at federally qualified health centers (FQHCs) and rural health clinics (RHCs). Now, certain behavioral health services at FQHCs and RHCs can be provided with “general” supervision instead of “direct” supervision. Practically, this means that behavioral health providers can now provide certain vital services without a doctor or advanced practice practitioner physically present on-site.
  4. Increasing reimbursement for crisis psychotherapy services to 150% of the usual Physician Fee Schedule rate when crisis care is provided outside of health care settings (i.e., in the community).
  5. Increasing reimbursement for substance use disorder treatment provided in an office setting to better reflect the actual costs of the services.

These changes are part of the 2024 Physician Fee Schedule Final Rule, 2024 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Final Rule, and 2025 Proposed Medicare Advantage and Part D rules.

If you have questions about expanded Medicare coverage and what that means for your patients or organization, or Medicare coverage of behavioral health services, please contact Member Daphne Kackloudis at dlkackloudis@bmdllc.com or Associate Jordan Burdick at jaburdick@bmdllc.com.


USCIS Policy Change Impacting Work Authorization: Advisory for Employers and Human Resources

USCIS has issued a policy memorandum pausing immigration benefit processing for individuals from 19 high-risk countries and requiring a re-review of certain previously approved cases. This change may affect work authorization, employment verification, and workforce stability. Employers and HR teams should review impacted employees and update compliance procedures.

CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule with Key Payment and Telehealth Updates

CMS issued the CY 2026 Medicare Physician Fee Schedule Final Rule on October 31, 2025, with changes effective January 1, 2026. The Final Rule includes increases to the conversion factor, a new efficiency adjustment, updates to practice expense methodology, permanent telehealth policy changes, revised payment for skin substitutes, expanded rules for Part B drugs and biologicals, enhanced policies for Rural Health Clinics and Federally Qualified Health Centers, and new care management and behavioral health services.

Ohio Department of Medicaid Updates: Key Changes to Physician Reimbursement Rates in Early Parenthood

The Ohio Department of Medicaid has proposed amending Ohio Administrative Code Rule related to covered Medicaid reimbursements for physicians. Beginning on January 1, 2026, they are proposing an increase to rates for prenatal care, childbirth, and infant care and provider visits.

Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.